Creating Formulation Intellectual Property during Drug Development – FAQ
Why must companies consider formulation patents? Pharmaceutical drug...
CMO versus CDMO: what’s the difference and how this decision is make or break for early phase drug development programs
Choosing the right organization to develop drugs is the single most...
Focusing on medicine for patients with swallowing difficulties
Vici Health Sciences, an innovative formulation development and cGMP...
Vici now offers cGMP API and intermediates synthesis services to support phase 1 clinical and GLP nonclinical studies
Vici Health Sciences, a Maryland-based CDMO is pleased to introduce...
High quality formulation development upfront saves drug developers valuable time and money
Drug development leaders must consider robustness and quality...
The Importance of Formulation Development in Successful Drug Development
Formulation development is a critical part of any drug development...
Vici Health Sciences Expands Staff and Footprint in Maryland
ELKRIDGE, MD. (PRWEB) DECEMBER 31, 2019 Vici Health...
Vici Health Sciences Expands Staff and Footprint in Maryland to Meet Customer Demands
ELKRIDGE, MD. (PRWEB) DECEMBER 31, 2019 Vici Health...
Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline
ELKRIDGE, MD. (PRWEB) DECEMBER 27, 2019 Vici Health Sciences is...
Phone
Location
6725 Santa Barbara Court,
Suite 107,
Elkridge, MD 21075